{"entity":{"type":"insider","cik":"0001655472","url":"/insider/0001655472","json_url":"/insider/0001655472.json","name":"TAHL CINDY","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":65,"n_filings":27,"first":"2017-10-17","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"TAHL CINDY","source":"filing","n_filings":27,"first_seen":"2017-10-17","last_seen":"2026-08-05"}],"transactions":[{"id":5944539,"accession":"0001193125-26-335019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-335019","line_url":"/filing/0001193125-26-335019#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38800.0,"shares_display":"38,800","price_per_share":2.4589,"price_display":"2.46","price_state":"stated","total_value":95405.32,"total_display":"95,405.32","total_whole":"95,405","shares_owned_after":589355.0,"shares_owned_after_display":"589,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-04","filed_date":"2026-08-05","scope":"insider"},{"id":6073418,"accession":"0001193125-26-234390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-234390","line_url":"/filing/0001193125-26-234390#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25590.0,"shares_display":"25,590","price_per_share":1.879,"price_display":"1.88","price_state":"stated","total_value":48083.61,"total_display":"48,083.61","total_whole":"48,084","shares_owned_after":628155.0,"shares_owned_after_display":"628,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-21","scope":"insider"},{"id":5870163,"accession":"0001193125-26-010356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-010356","line_url":"/filing/0001193125-26-010356#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10589.0,"shares_display":"10,589","price_per_share":1.0648,"price_display":"1.06","price_state":"stated","total_value":11275.1672,"total_display":"11,275.17","total_whole":"11,275","shares_owned_after":387081.0,"shares_owned_after_display":"387,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-12","scope":"insider"},{"id":4585096,"accession":"0000950170-25-102983","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-102983","line_url":"/filing/0000950170-25-102983#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9037.0,"shares_display":"9,037","price_per_share":1.0593,"price_display":"1.06","price_state":"stated","total_value":9572.8941,"total_display":"9,572.89","total_whole":"9,573","shares_owned_after":397670.0,"shares_owned_after_display":"397,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-04","filed_date":"2025-08-05","scope":"insider"},{"id":4193530,"accession":"0000950170-25-004823","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-004823","line_url":"/filing/0000950170-25-004823#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5654.0,"shares_display":"5,654","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":8763.7,"total_display":"8,763.70","total_whole":"8,764","shares_owned_after":336707.0,"shares_owned_after_display":"336,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-10","filed_date":"2025-01-13","scope":"insider"},{"id":3108049,"accession":"0000950170-24-003652","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-003652","line_url":"/filing/0000950170-24-003652#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10874.0,"shares_display":"10,874","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":47519.38,"total_display":"47,519.38","total_whole":"47,519","shares_owned_after":142361.0,"shares_owned_after_display":"142,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-10","scope":"insider"},{"id":8190283,"accession":"0001209191-23-054968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054968","line_url":"/filing/0001209191-23-054968#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24363.0,"shares_display":"24,363","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":58471.2,"total_display":"58,471.20","total_whole":"58,471","shares_owned_after":153235.0,"shares_owned_after_display":"153,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-09","filed_date":"2023-11-13","scope":"insider"},{"id":8722238,"accession":"0001209191-23-002977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002977","line_url":"/filing/0001209191-23-002977#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11553.0,"shares_display":"11,553","price_per_share":5.24,"price_display":"5.24","price_state":"stated","total_value":60537.72,"total_display":"60,537.72","total_whole":"60,538","shares_owned_after":177598.0,"shares_owned_after_display":"177,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-11","scope":"insider"},{"id":6925290,"accession":"0001209191-22-033481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-033481","line_url":"/filing/0001209191-22-033481#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":22.96,"price_display":"22.96","price_state":"stated","total_value":574000.0,"total_display":"574,000.00","total_whole":"574,000","shares_owned_after":189151.0,"shares_owned_after_display":"189,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":6985125,"accession":"0001209191-22-022495","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-022495","line_url":"/filing/0001209191-22-022495#line-3","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":38.85,"price_display":"38.85","price_state":"stated","total_value":971250.0,"total_display":"971,250.00","total_whole":"971,250","shares_owned_after":189151.0,"shares_owned_after_display":"189,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-04","scope":"insider"},{"id":6976517,"accession":"0001209191-22-003172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-003172","line_url":"/filing/0001209191-22-003172","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5419.0,"shares_display":"5,419","price_per_share":48.52824875438273,"price_display":"48.53","price_state":"stated","total_value":262974.58,"total_display":"262,974.58","total_whole":"262,975","shares_owned_after":156385.0,"shares_owned_after_display":"156,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider","n_lines":2},{"id":6843808,"accession":"0001209191-22-003051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-003051","line_url":"/filing/0001209191-22-003051","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7738.0,"shares_display":"7,738","price_per_share":46.43481519772551,"price_display":"46.43","price_state":"stated","total_value":359312.6,"total_display":"359,312.60","total_whole":"359,313","shares_owned_after":161911.0,"shares_owned_after_display":"161,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-12","scope":"insider","n_lines":2},{"id":6976268,"accession":"0001209191-22-000647","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-000647","line_url":"/filing/0001209191-22-000647","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":59.337055,"price_display":"59.34","price_state":"stated","total_value":2966852.75,"total_display":"2,966,852.75","total_whole":"2,966,853","shares_owned_after":169867.0,"shares_owned_after_display":"169,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider","n_lines":4},{"id":4793534,"accession":"0001209191-21-058930","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-058930","line_url":"/filing/0001209191-21-058930","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":58.82923976,"price_display":"58.83","price_state":"stated","total_value":2941461.988,"total_display":"2,941,461.99","total_whole":"2,941,462","shares_owned_after":119892.0,"shares_owned_after_display":"119,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-04","scope":"insider","n_lines":3},{"id":5498574,"accession":"0001209191-21-045182","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-21-045182","line_url":"/filing/0001209191-21-045182","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55534.0,"shares_display":"55,534","price_per_share":85.24045241113552,"price_display":"85.24","price_state":"stated","total_value":4733743.2842,"total_display":"4,733,743.28","total_whole":"4,733,743","shares_owned_after":108048.0,"shares_owned_after_display":"108,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-02","scope":"insider","n_lines":11},{"id":5518562,"accession":"0000899243-21-014635","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-21-014635","line_url":"/filing/0000899243-21-014635","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":83.81096778,"price_display":"83.81","price_state":"stated","total_value":2514329.0334,"total_display":"2,514,329.03","total_whole":"2,514,329","shares_owned_after":128828.0,"shares_owned_after_display":"128,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-02","scope":"insider","n_lines":8},{"id":5091004,"accession":"0001209191-21-004749","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-004749","line_url":"/filing/0001209191-21-004749","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":114.76112222285714,"price_display":"114.76","price_state":"stated","total_value":4016639.2778,"total_display":"4,016,639.28","total_whole":"4,016,639","shares_owned_after":109200.0,"shares_owned_after_display":"109,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider","n_lines":4},{"id":4611602,"accession":"0001209191-21-003339","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-003339","line_url":"/filing/0001209191-21-003339","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3254.0,"shares_display":"3,254","price_per_share":110.81336816226184,"price_display":"110.81","price_state":"stated","total_value":360586.7,"total_display":"360,586.70","total_whole":"360,587","shares_owned_after":91957.0,"shares_owned_after_display":"91,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider","n_lines":3},{"id":4611580,"accession":"0001209191-21-003339","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-003339","line_url":"/filing/0001209191-21-003339#line-4","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2755.0,"shares_display":"2,755","price_per_share":117.599,"price_display":"117.60","price_state":"stated","total_value":323985.245,"total_display":"323,985.24","total_whole":"323,985","shares_owned_after":96763.0,"shares_owned_after_display":"96,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider"},{"id":4611572,"accession":"0001209191-21-003339","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-003339","line_url":"/filing/0001209191-21-003339#line-3","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2451.0,"shares_display":"2,451","price_per_share":117.154,"price_display":"117.15","price_state":"stated","total_value":287144.454,"total_display":"287,144.45","total_whole":"287,144","shares_owned_after":94312.0,"shares_owned_after_display":"94,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider"},{"id":4611564,"accession":"0001209191-21-003339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-003339","line_url":"/filing/0001209191-21-003339#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001655472","owner_name":"TAHL CINDY","owner_display_name":"TAHL CINDY","owner_url":"/insider/0001655472","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":872.0,"shares_display":"872","price_per_share":115.799,"price_display":"115.80","price_state":"stated","total_value":100976.728,"total_display":"100,976.73","total_whole":"100,977","shares_owned_after":93440.0,"shares_owned_after_display":"93,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider"}],"collapsed":true,"next_cursor":"2021-01-08|4611564","ledger_fault":false,"count":{"value":65,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":65,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":65},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Officer","n_filings":27,"first_seen":"2017-10-17","last_seen":"2026-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001655472","retrieved_at":"2026-08-24T03:56:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}